Biopure case study pdf

Biopure corporation was a biopharmaceutical company that specialized in oxygen therapeutics blood substitutes for both human and veterinary use. The oxygen technology uses hemoglobinbased oxygen carrying molecules in solution hbocs to increase oxygen transfer to the. Overview the following is a writeup of case study based on biopure corporation. Biopure final free download as powerpoint presentation. In conclusion, since the fda approval for human blood substitute is still uncertain, biopure should immediately launch oxyglobin. Biopure case executive summary this paper analyzes possible scenarios of biopures products launching and provides marketing plan of the recommended one. In litigation brought by the securities and exchange commission sec against biopure corporation biopure and several current and former officers of the company involving its drug hemopure, counsel for biopure retained cornerstone research to work with professor paul gompers of harvard business school.

The study shows that biopure should immediately launch oxyglobin rather than wait for hemopures fda. Biopure has pioneered the design, development and delivery of innovative bioprocessing fluid path components since 1998. Biopure are specialists in the design and manufacture of singleuse fluid path components and connectors for use in the pharmaceutical and biotech industries. The company developed, manufactured, and marketed oxygen therapeutics, designed to transport oxygen to the bodys tissues. Jan 06, 2020 biopure corporation case pdf january 6, 2020 it is early and biopure corp. The study involved a condition survey of the plaster on the ceilings and around the windows in each atrium. Consequently the company soon has to further develop oxyglobin, strengthen its unique characteristics, while ensuring the quality of the product, to move away from potential competitors. Biopure maintains a website at the following internet address. Jul 02, 2019 biopure corporation case pdf it is early and biopure corp.

Biopure case study pdf biopure case summary course. Biopure however, the launching of oxyglobin is directly relating to the future of hemopure which is primary goal of the company in development of a human blood substitute. We offer the highest quality nutritional supplements, formulated from the purest raw ingredients. Biopure was retained by the developer to remove all the hardwood flooring, remediate the building and install new flooring. We offer an evolving collection of potent, highquality nutritional supplements selected by our naturopathic and medical advisors. International strategic management biopure case study. Case study solution, this is the beginning of 1998 and biopure corporation, a small biopharmaceutical company, not sales revenue in its tenyear history, has just received gove.

It would also ensure a steady revenue stream which will increase biopures chances of achieving a lucrative ipo risk mitigation. Type the company name case analysis of biopure corporation situation analysis \u0001 oxyglobin. Veterinary blood market blood transfusions were infrequent about 30% of cases would have benefitted significantly from transfusions, only. Business case biopure brenda leeneman lilian van donk marit van barreveld simone huygens background biopure enters the field of blood substitutes. Jul 22, 2019 biopure case study pdf posted on july 22, 2019 by admin biopure case summary course. A virtually identical product for the human market, hemopure, is in the final stages of testing by biopure and is expected to gain approval. Biopure corporation case solution,biopure corporation case analysis, biopure corporation case study solution, introduction biopure corporation was founded in the year 1984. Biopure casestudy group 8 contents the product case facts biopure swot the.

Carl rausch, president and ceo of biopure corporation from. Oct 26, 20 biopure corporation written case study i. The estimates for market potential for both the products are shown. Buy books, tools, case studies, and articles on leadership, strategy, innovation, and. The company has been a privately owned pharmaceutical firm. The study shows that biopure should immediately launch oxyglobin rather than wait for hemopures fda approval then launch both products simultaneously. Biopure market potential exercise suggested solution question 1 how would you revise the market potential for hemopure. Globing is the first blood substitute for the veterinary market and is ready for launch. Wmftg has launched biopure silicone transfer tubing to provide a safe, reliable and valuebased solution for a wide range of bioprocess fluid transfer. Biopure corporation case study richard addington phd table of contents 1.

Biopure corp case study overview of biopure biopure corporation was a biopharmaceutical company that specialized in oxygen therapeutics for both human and veterinary use. Hemopure is another new blood substitute for the human market and it will. Biopure has a chance to be the first player to enter this market and recover its research and development costs within two years. Biopures phase iii clinical trial of hemopure meets. You can also send us an email or find your nearest distributor. Pourer corporation case study pourer corporation have two new products that are globing and humored. Carl had only been with the company for six months, but expressed he was ready to begin recruiting people. A case study biopure corporation specializes in blood substitutes for transfusion patients, both in the veterinary market and the human market. Biopure case study biopure corp case study overview of. Biopure corporation was a biopharmaceutical company that specialized in oxygen. Rausch, the contents of this letter will provide you the information and analysis you will require in order to make an effective decision on the timely release of your biopure products.

Oxyglobin and hemopure are two blood substitutes that biopure corporation was developing. Google biopure case study mkt 6301 09162016 sruthi sara jacob. Apr 04, 2020 biopure case study pdf biopure case summary course. Financial projections sensitivity analysis 15 executive summary in 1998, biopure corporation is one of the three legitimate contenders in the emerging field of blood substitutes. Our goal at biopure is to create an unparalleled culture of authenticity. Biopure corporation case pdf it is early and biopure corp. Biopure corporation case solution and analysis, hbr case. A virtually identical product for the human market, hemopure, is in the final stages of testing by. Biopure case analysis veterinary physician blood transfusion. Pdf international strategic management biopure study. This is considered a tough job, which involves many responsible.

The best foursegment solution to the usage problem includes these categories. International strategic management biopure study case. Biopure corporation, founded in 1984, privately owned. Biopure corporation has two new products that are oxyglobin and hemopure. Essay about case study biopure corporation 599 words. Biopure corporation, founded in 1984, privately owned pharmaceutical firm. Estimation of veterinary market and per year 14 exhibit 4. Issue oxyglobin and hemopure are two blood substitutes that biopure corporation was developing. Oxyglobin was recently approved by the fda for veterinary use while hemapure is. Indian institute of management kozhikode marketing management case analysis. After inspections, biopure provided a detailed analytical. A virtually identical product for the human market, hemopure, is in the final stages of testing by biopure and is expected to gain approval within one to two years.

Biopure works through a unique combination of living microbes and enzymes that first break down, and then digest eat away the organic waste that accumulates in an evacuation system. Each of you must read and prepare the case individually, and come prepared to discuss the following questions. Minor case study 2500 words 35% of total grade read the buddys snack company case study below and answer all the following questions. Pgp14258 alok kumar pgp14279 lokesh singh pgp14280 mahtaab kajla pgp14283 naveen vyas pgp14303. As the case mentioned that the baxter international and northfield laboratories were the most powerful competitors for biopure corporation.

Once biopure secures phase 3 fda approval, they should plan to. Biopure thermally mapped the interior surfaces using an infrared camera in conjunction with moisture readings and corresponding photograph and video footage of the delaminated areas. Buss 5114 people, organisations and leadership study period 1 2014 assessment task 2. Biopure is preparing the phase iii study report and is assembling an electronic biologic license application ebla, for perioperative use of hemopure in patients undergoing elective surgery, based on data from the pivotal clinical trial and 19 other trials. Biopure corporation case writeup page 1 background analysis biopure corporation biopure was founded in 1984 with the. Biopure final strategic management business economics. Case study analysis diana hamilton comm215 april 16, 2012 lyn wolf title of paper carl robins, began working for abc, incorporated, about six months ago as a campus recruiter.

New transfer tubing from biopure wmftg id watsonmarlow. Through a link to a thirdparty content provider, this corporate website provides free access to biopure s annual reports on form 10k, quarterly reports on form 10q, current reports on. Even when biopure was primarily focused on developing a human blood substitute, the opportunistic development and later approval of oxyglobin, an animal blood substitute, is a valuable opportunity that has to be. Our strong market focus, aligned with a global presence, ensures biopure will continue to be the market leader in singleuse technology for many years. Human market hemopure veterinary market oxyglobin oxyglobin already received final fda approval and is ready for launch hemopure. Biopure biobarbs hose tail to triclamp adapters are produced from dmf listed polypropylene that complies with fda and usp class vi test protocols. Oxyglobin is the first new blood substitute for the veterinary market and is ready for consumer use. View homework help 51085262caseanalysisbiopurecorporation. Tubing technology pumps polymers for dewatering efficiency. Market analysis ahuman 14 million units of rbcs were donated in the united states in 1995, 12.

The company developed two products, hamopure and oxyglobin. Oxyglobin was recently approved by the fda for veterinary use while hemapure is estimated to be approved in two years for human use. Jul 26, 2019 biopure corporation case pdf posted on july 26, 2019 by admin it is early and biopure corp. However, in 1998, biopure faced the monumental decision of whether to begin selling oxyglobin, a blood substitute, to the veterinary market or to wait until hemoglobin, a blood. Complete evacuation system cleaner hungry microbes for organic waste management.